Press review
The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.
OncologyNeutrophils: hidden accomplices in colorectal cancer?
By Ana Espino | Published on March 23, 2026 | 3 min readColorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. While the role of T lymphocytes in tumor immunosurveillance is well established, the involvement of neutrophils—key cells of innate immunity—is drawing increasing attention. Long regarded as simple mediators of acute inflammation, neutrophils are
NeurologyADHD: towards a role of local sleep in attention disorders
By Elodie Vaz | Published on March 20, 2026 | 3 min readAttention Deficit Hyperactivity Disorder (ADHD) affects approximately 2.5% of adults and is characterized by persistent difficulties with attention, increased distractibility, and inattention errors. Despite a well-established clinical description, its neurobiological foundations remain incompletely understood, limiting the identification of
Emergency MedicineArtificial intelligence: a new ally for diagnosis in pediatric emergency care
By Elodie Vaz | Published on March 19, 2026 | 3 min readElbow injuries are a common reason for consultation in pediatric emergency departments. However, their radiological diagnosis remains challenging. In children, the skeleton is still developing and includes numerous growth plates that are invisible or poorly visible on X-rays. In addition, some fractures can be extremely subtle. In this contex
Allergology and ImmunologySRC enzyme: a new target for anticancer antibodies
By Elodie Vaz | Published on March 19, 2026 | 3 min readFor over half a century, the oncogenic enzyme SRC has held a central place in cancer research. Identified in the 1970s as the first oncogene by J. Michael Bishop and Harold Varmus—a discovery awarded the Nobel Prize in 1989—this finding profoundly transformed the genetic understanding of cancer. SRC encodes an enzyme involved in intracellular
General MedicineUltra-processed foods under scrutiny for their effects on bone health
By Elodie Vaz | Published on March 18, 2026 | 3 min readBone fragility is a major public health concern. It is characterized in particular by a reduction in bone mineral density (BMD), a key factor in the occurrence of fractures—especially hip fractures, which are associated with significant morbidity and mortality in adults. Osteoporosis and osteoporotic fractures result from an imbalance between
Physical Medicine and RehabilitationChronic ankle instability: the end of standard protocols?
By Ana Espino | Published on March 18, 2026 | 3 min readChronic ankle instability (CAI) is a common complication of lateral ankle sprains, with nearly 40% of patients developing persistent symptoms after an initial injury. This condition is characterized by a heterogeneous clinical course, combining proprioceptive deficits, impaired postural control, muscle weakness, and delayed neuromuscular resp
OncologyCAR-T cells in colorectal cancer: the challenge of solid tumors
By Ana Espino | Published on March 18, 2026 | 3 min readColorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Despite advances in surgery, chemotherapy, and targeted therapies, metastatic CRC continues to carry a poor prognosis. Therapeutic options remain limited after failure of standard treatment lines. Immunotherapy has transformed the management of ce
General MedicineMyocardial infarction: a single-dose drug to support heart repair
By Elodie Vaz | Published on March 17, 2026 | 3 min readMyocardial infarction is one of the leading causes of cardiovascular mortality and disability worldwide. Even when patients survive the acute event, the consequences for the heart can be long-lasting. The blockage of a coronary artery deprives tissue of oxygen, leading to the death of part of the heart muscle. In the weeks that follow, the he
OncologyColorectal cancer: detecting disease before the tumor appears?
By Ana Espino | Published on March 17, 2026 | 3 min readColorectal cancer (CRC) is the third most common cancer worldwide, with nearly 2 million new cases each year. Despite the existence of screening programs, mortality remains high, with 5-year survival dropping from 91% at early stage to 15% at stage IV. At the same time, the concerning rise in early-onset cases (
OncologyReprogramming the immune system: a new strategy against ovarian cancer
By Elodie Vaz | Published on March 16, 2026 | 3 min read Ovarian cancer remains one of the most feared gynecological cancers, largely due to late diagnosis and a strong tendency to develop therapeutic resistance. The most common and aggressive form is high-grade serous ovarian cancer, which often responds initially to chemotherapy but frequently becomes refractory to treatment over time. While imm
OthersNLR: a warning signal for vertebral fracture?
By Ana Espino | Published on March 16, 2026 | 3 min readOsteoporosis is a systemic disease characterized by reduced bone mineral density and deterioration of bone microarchitecture. Vertebral fractures account for approximately 40% of osteoporotic fractures and are frequently asymptomatic, with underdiagnosis rates reaching up to 60%. Their occurrence increases the risk of subsequent fractures by
OncologyMedicinal plants: an asset against colorectal cancer?
By Ana Espino | Published on March 16, 2026 | 3 min readColorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Despite advances in surgery, chemotherapy, targeted therapies, and immunotherapy, survival in metastatic disease remains limited. Therapeutic resistance, cumulative toxicity, and tumor heterogeneity represent major clinical challenges. In this con